Gene therapy is facing its biggest challenge yet
After finally gaining traction as a potential treatment for certain genetic disorders, gene therapy tackles the challenge of sickle-cell disease.
Related Articles
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
Nature Medicine – As presented at the 2025 ASCO GI Cancers Symposium: in the phase 3 BREAKWATER trial, patients with previously untreated BRAF V600E metastatic…
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
Nature Medicine – As presented at the 2025 ASCO GI Cancers Symposium: in the phase 3 BREAKWATER trial, patients with previously untreated BRAF V600E metastatic…
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
Nature Medicine – As presented at the 2025 ASCO GI Cancers Symposium: in the phase 3 BREAKWATER trial, patients with previously untreated BRAF V600E metastatic…
De novo designed proteins neutralize lethal snake venom toxins
Nature – Deep learning methods have been used to design proteins that can neutralize the effects of three-finger toxins found in snake venom, which could…
Early intervention with daratumumab improves survival for patients with high-risk smouldering myeloma
Nature Reviews Clinical Oncology – Recent results from the phase III AQUILA trial demonstrate the benefit of fixed-duration monotherapy with daratumumab over observation in patients…
Extracellular vesicles from pancreatic cancer and its tumour microenvironment promote increased Schwann cell migration
British Journal of Cancer – Extracellular vesicles from pancreatic cancer and its tumour microenvironment promote increased Schwann cell migration
Novel treatment strategy targeting interleukin-6 induced by cancer associated fibroblasts for peritoneal metastasis of gastric cancer
Scientific Reports – Novel treatment strategy targeting interleukin-6 induced by cancer associated fibroblasts for peritoneal metastasis of gastric cancer
Systemic IFN-I combined with topical TLR7/8 agonists promotes distant tumor suppression by c-Jun-dependent IL-12 expression in dendritic cells
Nature Cancer – Sanlorenzo et al. propose a strategy to boost immunotherapy by combining topically applied TLR7/8 agonists with systemic interferon-I, sensitizing dendritic cells to…
A gut microorganism turns the dial on sugar intake
Nature Microbiology – A Bacteroides vulgatus metabolite, pantothenate, induces secretion of the hormones GLP1 in the gut and FGF21 in the liver, which act on…
Hemoglobin Glycation Index and Its Implications in Diabetes and Cardiovascular Health | Nature Research Intelligence
Learn how Nature Research Intelligence gives you complete, forward-looking and trustworthy research insights to guide your research strategy.
